Agregator de Jurnale Medicale de Specialitate

Agregator de Jurnale Medicale de Specialitate

Agregatorul de știri și noutăți prezintă cele mai noi studii clinice și noutăți despre tratamente medicale oncologice, tratamente de radioterapie și radiochirurgie, publicate în jurnalele medicale de specialitate la nivel internatțional:

To evaluate the tolerability and maximum tolerated dose (MTD) of sorafenib administered concurrently with palliative radiotherapy. [...]
joi, Iun 29, 2017
Source: Jurnalul de Radioterapie & Oncologie
Idelalisib is approved for the treatment of relapsed chronic lymphocytic leukemia together with Rituximab and for monotherapy of follicular B-cell non-Hodgkin’s lymphoma and small lymphocytic lymphoma. It is a... [...]
mie, Iun 28, 2017
Source: Jurnalul American de Radioterapie Oncologică
A meta-analysis of CXCL12 expression for cancer prognosis British Journal of Cancer 117, 124 (27 June 2017). doi:10.1038/bjc.2017.134 Authors: Harsh Samarendra, Keaton Jones, Tatjana Petrinic, Michael A Silva, Srikanth Reddy, Zahir Soonawalla & Alex Gordon-Weeks [...]
mar, Iun 27, 2017
Source: Jurnalul de Oncologie UK
A phase Ib study of pembrolizumab plus chemotherapy in patients with advanced cancer (PembroPlus) British Journal of Cancer 117, 33 (27 June 2017). doi:10.1038/bjc.2017.145 Authors: Glen J Weiss, Jordan Waypa, Lisa Blaydorn, Jessica Coats, Kayla McGahey, Ashish [...]
mar, Iun 27, 2017
Source: Jurnalul de Oncologie UK
CBF1 is clinically prognostic and serves as a target to block cellular invasion and chemoresistance of EMT-like glioblastoma cells British Journal of Cancer 117, 102 (27 June 2017). doi:10.1038/bjc.2017.157 Authors: D Maciaczyk, D Picard, L Zhao, K [...]
mar, Iun 27, 2017
Source: Jurnalul de Oncologie UK